| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Suparna Saha, Soumava Mukherjee, Gautam Guha, Debashis Mukhopadhya. Dynamics of AQP4 upon exposure to seropositive patient serum before and after Rituximab therapy in Neuromyelitis Optica: A cell-based study. Journal of neuroimmunology. vol 361. 2021-11-24. PMID:34715591. |
neuromyelitis optica (nmo) is an autoimmune inflammatory disease that affects the optic nerves and spinal cord. |
2021-11-24 |
2023-08-13 |
Not clear |
| Yang Yang, Lifeng Chen, Lei Wu, Jiarui Yao, Na Wang, Xiaoqing Su, Dongmei Li, Lina Han, Weiping Wu, Dehui Huang, Tianyu Jiang, Zhenfu Wan. Effective Rituximab Treatment in Patients with Neuromyelitis Optica Spectrum Disorders Compared with Azathioprine and Mycophenolate. Neurology and therapy. 2021-11-19. PMID:34797551. |
as an autoimmune central nervous system disease characterized by inflammation and demyelination, neuromyelitis optica (nmo) has been extensively investigated. |
2021-11-19 |
2023-08-13 |
Not clear |
| Jonathan Giovannelli, Jonathan Ciron, Mikael Cohen, Ho-Jin Kim, Su-Hyun Kim, Jan-Patrik Stellmann, Ingo Kleiter, Morgan McCreary, Benjamin M Greenberg, Romain Deschamps, Bertrand Audoin, Elisabeth Maillart, Caroline Papeix, Nicolas Collongues, Bertrand Bourre, David Laplaud, Xavier Ayrignac, Françoise Durand-Dubief, Aurélie Ruet, Sandra Vukusic, Romain Marignier, Luc Dauchet, Hélène Zephi. A meta-analysis comparing first-line immunosuppressants in neuromyelitis optica. Annals of clinical and translational neurology. vol 8. issue 10. 2021-11-16. PMID:34505407. |
as phase iii trials have shown interest in innovative but expensive drugs in the treatment of neuromyelitis optica spectrum disorder (nmosd), data are needed to clarify strategies in the treatment of neuromyelitis optica (nmo). |
2021-11-16 |
2023-08-13 |
Not clear |
| Abdu Kisekka Musubire, Judith Derdelinckx, Tatjana Reynders, David B Meya, Paul R Bohjanen, Patrick Cras, Barbara Willeken. Neuromyelitis Optica Spectrum Disorders in Africa: A Systematic Review. Neurology(R) neuroimmunology & neuroinflammation. vol 8. issue 6. 2021-11-16. PMID:34663674. |
neuromyelitis optica (nmo) is a cns inflammatory disease that predominantly affects the optic nerves and the spinal cord. |
2021-11-16 |
2023-08-13 |
Not clear |
| Agnieshka Agasing, James L Quinn, Gaurav Kumar, Robert C Axtel. Interferon-β Intensifies Interleukin-23-Driven Pathogenicity of T Helper Cells in Neuroinflammatory Disease. Cells. vol 10. issue 8. 2021-11-15. PMID:34440908. |
however, 25-40% of patients are nonresponsive to this therapy, and it worsens neuromyelitis optica (nmo), another neuroinflammatory disease. |
2021-11-15 |
2023-08-13 |
mouse |
| Melanie Lohrberg, Anne Winkler, Jonas Franz, Franziska van der Meer, Torben Ruhwedel, Nikoloz Sirmpilatze, Rakshit Dadarwal, Ronja Handwerker, Daniel Esser, Kerstin Wiegand, Christian Hagel, Andreas Gocht, Fatima Barbara König, Susann Boretius, Wiebke Möbius, Christine Stadelmann, Alonso Barrantes-Free. Lack of astrocytes hinders parenchymal oligodendrocyte precursor cells from reaching a myelinating state in osmolyte-induced demyelination. Acta neuropathologica communications. vol 8. issue 1. 2021-11-09. PMID:33357244. |
astrocytic damage, which is prominent in neuroinflammatory diseases like neuromyelitis optica (nmo) and multiple sclerosis (ms), is considered the primary event during formation of cpm lesions. |
2021-11-09 |
2023-08-13 |
human |
| Qi Zhang, Shanshan Pei, Zheyi Zhou, Zhanhang Wang, Yu Peng, Jinyu Chen, Honghao Wan. High Level of Serum and Cerebrospinal Fluid of Heparan Sulfate and Hyaluronic Acid Might Be a Biomarker of Severity of Neuromyelitis Optica. Frontiers in immunology. vol 12. 2021-11-08. PMID:34367165. |
neuromyelitis optica (nmo), multiple sclerosis (ms) and autoimmune glial fibrillary acidic protein (gfap) astrocytopathy are idiopathic inflammatory demyelinating diseases (iidds) that mainly present as encephalomyelitis. |
2021-11-08 |
2023-08-13 |
Not clear |
| Anna Presicci, Maria Serra, Mariaclara Achille, Elvita Caputo, Lucia Margar. Pediatric Optic Neuritis: Description of Four Cases and Review of the Literature. Children (Basel, Switzerland). vol 8. issue 10. 2021-10-26. PMID:34682120. |
pon has a high impact on the quality of life as it may or may not evolve into other acquired demyelinating syndromes (adss), such as multiple sclerosis (ms), neuromyelitis optica (nmo), or other syndromes related to the myelin oligodendrocyte glycoprotein igg antibodies (mog-igg). |
2021-10-26 |
2023-08-13 |
Not clear |
| Melina V Jones, Nicolas Collongues, Jerome de Seze, Makoto Kinoshita, Yuji Nakatsuji, Michael Lev. Review of Animal Models of Neuromyelitis Optica. Multiple sclerosis and related disorders. vol 1. issue 4. 2021-10-21. PMID:24555175. |
neuromyelitis optica (nmo) is a recurrent neuroinflammatory disease of the optic nerves and spinal cord associated with the anti-aquaporin-4 (aqp4) antibody biomarker, nmo-igg. |
2021-10-21 |
2023-08-12 |
human |
| Dorlan J Kimbrough, Kazuo Fujihara, Anu Jacob, Marco A Lana-Peixoto, Maria Isabel Leite, Michael Levy, Romain Marignier, Ichiro Nakashima, Jacqueline Palace, Jérôme de Seze, Olaf Stuve, Silvia N Tenembaum, Anthony Traboulsee, Emmanuelle Waubant, Brian G Weinshenker, Dean M Wingerchu. Treatment of Neuromyelitis Optica: Review and Recommendations. Multiple sclerosis and related disorders. vol 1. issue 4. 2021-10-21. PMID:24555176. |
neuromyelitis optica (nmo) is an autoimmune demyelinating disease preferentially targeting the optic nerves and spinal cord. |
2021-10-21 |
2023-08-12 |
Not clear |
| E Garcia-Martin, I Pinilla, V Pueyo, L Gil, J Martinez-Morales, J Fernande. Bilateral Internuclear Ophthalmoplegia in a Patient with Devic's Neuromyelitis Optica. Case reports in neurology. vol 2. issue 3. 2021-10-20. PMID:21113284. |
an unusual presentation of devic's neuromyelitis optica (nmo) disease associated with bilateral internuclear ophthalmoplegia (ino) is described. |
2021-10-20 |
2023-08-12 |
Not clear |
| Ryuto Yoshida, Takuya Sasaki, Takashi Sunouchi, Masayuki Ueda, Mizuki Kitamura, Takahiro Nakayama, Jun Saito, Ichiro Imafuk. Neuromyelitis Optica Complicated by Ornithine Transcarbamylase Deficiency Treated Safely with Pulse Steroid Therapy. Internal medicine (Tokyo, Japan). vol 60. issue 20. 2021-10-19. PMID:33867389. |
we encountered a 36-year-old woman with neuromyelitis optica (nmo) complicated by ornithine transcarbamylase (otc) deficiency. |
2021-10-19 |
2023-08-13 |
Not clear |
| Carolina M Rimkus, Vinicius Andreoli Schoeps, Mateus Boaventura, Luis Filipe Godoy, Samira Luisa Apostolos-Pereira, Ana Luisa Calich, Dagoberto Callegaro, Leandro Tavares Lucato, Alex Rovira, Jaume Sastre-Garriga, Claudia da Costa Leit. Drug-related demyelinating syndromes: understanding risk factors, pathophysiological mechanisms and magnetic resonance imaging findings. Multiple sclerosis and related disorders. vol 55. 2021-10-19. PMID:34332456. |
some drugs and medications can precipitate immune system deregulations, which might be confused with recurrent demyelinating diseases, such as multiple sclerosis (ms) and neuromyelitis optica spectrum disorders (nmo), exacerbations of an existing disease, neoplastic lesions or other conditions. |
2021-10-19 |
2023-08-13 |
Not clear |
| Sukhee Cho, Hyein Lee, Minkyo Jung, Kirim Hong, Seung-Hwa Woo, Young-Sam Lee, Byoung Joon Kim, Mi Young Jeon, Jinsoo Seo, Ji Young Mu. Neuromyelitis optica (NMO)-IgG-driven organelle reorganization in human iPSC-derived astrocytes. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. vol 35. issue 10. 2021-10-12. PMID:34460995. |
neuromyelitis optica (nmo)-igg-driven organelle reorganization in human ipsc-derived astrocytes. |
2021-10-12 |
2023-08-13 |
human |
| Sukhee Cho, Hyein Lee, Minkyo Jung, Kirim Hong, Seung-Hwa Woo, Young-Sam Lee, Byoung Joon Kim, Mi Young Jeon, Jinsoo Seo, Ji Young Mu. Neuromyelitis optica (NMO)-IgG-driven organelle reorganization in human iPSC-derived astrocytes. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. vol 35. issue 10. 2021-10-12. PMID:34460995. |
neuromyelitis optica (nmo) is an autoimmune disease that primarily targets astrocytes. |
2021-10-12 |
2023-08-13 |
human |
| Shinya Oginezawa, Shoko Hongo, Yoshitaka Umeda, Maiko Umeda, Mutsuo Oyake, Nobuya Fujit. [A case of neuromyelitis optica associated with pulmonary Mycobacterium avium complex disease]. Rinsho shinkeigaku = Clinical neurology. vol 61. issue 9. 2021-09-30. PMID:34433747. |
on the basis of these findings, the patient was diagnosed as having neuromyelitis optica (nmo), when chest ct also demonstrated exacerbation of pulmonary lesions. |
2021-09-30 |
2023-08-13 |
Not clear |
| Ahya Ali, Deanna Dwyer, Qi Wu, Qin Wang, Catherine A Dowling, David A Fox, Dinesh Khanna, Gregory A Poland, Yang Mao-Draaye. Characterization of humoral response to COVID mRNA vaccines in multiple sclerosis patients on disease modifying therapies. Vaccine. vol 39. issue 41. 2021-09-30. PMID:34483021. |
little is known about covid-19 mrna vaccine humoral immune responses in patients with central nervous system autoimmune demyelinating diseases, multiple sclerosis (ms) and neuromyelitis optica (nmo), who are on b-cell depleting therapies (bcdt) and other disease modifying therapies (dmts). |
2021-09-30 |
2023-08-13 |
human |
| Aaron Winter, Bart Chwalis. MRI Characteristics of NMO, MOG and MS Related Optic Neuritis. Seminars in ophthalmology. vol 35. issue 7-8. 2021-09-23. PMID:33395326. |
acute isolated optic neuritis can be the initial presentation of demyelinating inflammatory central nervous system disease related to multiple sclerosis (ms), neuromyelitis optica (nmo) or myelin oligodendrocyte glycoprotein antibody disease (mog-ad). |
2021-09-23 |
2023-08-13 |
Not clear |
| Nina Javadian, Hana Magrouni, Majid Ghaffarpour, Sakineh Ranji-Burachalo. Severe Relapses of Neuromyelitis Optica Spectrum Disorder During Treatment With Dimethyl Fumarate. Clinical neuropharmacology. vol 44. issue 1. 2021-09-23. PMID:33449476. |
neuromyelitis optica spectrum disorder (nmosd) is an autoimmune demyelinating disease of the central nervous system, characterized by a specific antibody that selectively binds aquaporin-4 channel.this is a report of an nmosd case, with severe attacks of optic neuritis and myelitis after initiate of dimethyl fumarate (dmf).we suggested that dmf could deteriorate the neuromyelitis optica (nmo) disease course, which results in serious morbidity and mortality in patients. |
2021-09-23 |
2023-08-13 |
Not clear |
| Agnieszka Wlodarczyk, Reza Khorooshi, Joanna Marczynska, Inge R Holtman, Mark Burton, Kirstine Nolling Jensen, Morten Blaabjerg, Morten Meyer, Mads Thomassen, Bart J L Eggen, Nasrin Asgari, Trevor Owen. Type I interferon-activated microglia are critical for neuromyelitis optica pathology. Glia. vol 69. issue 4. 2021-09-20. PMID:33241604. |
neuromyelitis optica (nmo) is an inflammatory disease of the central nervous system (cns) most frequently mediated by serum autoantibodies against the water channel aquaporin 4, expressed on cns astrocytes, resulting in primary astrocytopathy. |
2021-09-20 |
2023-08-13 |
mouse |